New eye drug aims to clear Vision-Damaging material in wet AMD
NCT ID NCT07403825
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests the drug faricimab (Vabysmo) in 100 people aged 50+ with wet age-related macular degeneration who have a specific type of harmful material under their retina. The goal is to see if the drug can clear that material by week 16. Participants receive injections into the eye, and researchers will track how well the treatment works using advanced imaging.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- faricimab (Vabysmo) injection
- What this could lead to
- If successful, this could show that faricimab effectively clears harmful material under the retina, potentially improving vision for people with a specific type of wet age-related macular degeneration.
- What could go wrong
- This is a relatively small, early-phase (Phase 4) study with only 100 participants. Results may not apply to all patients, and not everyone may see improvement. Eye injections carry risks like infection or inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR DEGENERATION, AGE RELATED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinica Barraquer
RECRUITINGBarcelona, Catalonia, 08021, Spain
-
Hospital Arruzafa
RECRUITINGCórdoba, Andalusia, 14012, Spain
-
Hospital Clínico San Carlos
RECRUITINGMadrid, Madrid, 28040, Spain
-
Hospital Clínico Universitario de Valladolid
RECRUITINGValladolid, Castille and León, 47003, Spain
-
Hospital General Universitario Valencia
RECRUITINGValencia, Valencia, 46014, Spain
-
Hospital Puerta de Hierro Majadahonda
RECRUITINGMajadahonda, Madrid, 28222, Spain
-
Hospital Universitario Basurto
RECRUITINGBilbao, Bizkaia, 48013, Spain
-
Hospital Universitario Nuestra Señora del Perpétuo Socorro
RECRUITINGAlbacete, Castille-La Mancha, 02006, Spain
-
Instituto Oftalmologico Fernandez-Vega
RECRUITINGOviedo, Principality of Asturias, 33012, Spain
-
Oftalvist Valencia
RECRUITINGBurjassot, Valencia, 46100, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Longer-Lasting eye injection could cut treatment visits for macular disease
- Can a new eye injection save vision in wet AMD?
- Eye injection aims to tame leading causes of blindness
- Higher-Dose eye injection may help wet AMD patients who Didn't respond to standard treatments
- New eye drug aims to save sight in wet AMD
- Withdrawn study sought better way to time eye injections